EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons

Borah Kim, Sang-Hyuk Lee, Yen Kuang Yang, Jong-Il Park, Young-Chul Chung

Schizophrenia Research and Treatment · 2012

DOI: 10.1155/2012/560836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Research and Treatment, 2012. Verfasst von Borah Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, CHA Bundang Medical Center, CHA University, 59 Yatap-ro, Bundang-gu, Seongnam-si 463-712, Gyeonggi-do, Republic of Korea. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical and psychosocial deterioration associated with schizophrenia occurs within the first few years following the onset of the illness. Therefore, to improve the long-term prognosis, it is important to provide schizophrenia patients with intensive treatment following their first episode. Relapse is highly associated with partial medication adherence or nonadherence in patients with first-episode schizophrenia. Recent studies suggest that long-acting injectable (LAI) antipsychotics compared with oral antipsychotics are more effective for medication adherence and relapse prevention. Moreover, some clinical guidelines for the treatment of schizophrenia suggested that LAI antipsychotics should be considered when patients are nonadherent “at any stage.” Decreased compliance is a common cause of relapse during the initial stages of the disease. Therefore, LAI antipsychotics should be highly considered when treating patients with first-episode schizophrenia. In the present paper, clinical trial data and current guidelines on the use of LAI antipsychotics for first-episode schizophrenia are discussed as well as the pros and cons of this treatment option.

Autor:innen und Institutionen

  • Department of Psychiatry, CHA Bundang Medical Center, CHA University, 59 Yatap-ro, Bundang-gu, Seongnam-si 463-712, Gyeonggi-do, Republic of Korea.

Zitieren

APA

Kim, B., Lee, S. H., Yang, Y. K., Park, J. I., & Chung, Y. C. (2012). Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons. Schizophrenia Research and Treatment. https://doi.org/10.1155/2012/560836

Vancouver

Kim B, Lee SH, Yang YK, Park JI, Chung YC. Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons. Schizophrenia Research and Treatment. 2012. doi:10.1155/2012/560836

BibTeX
@article{Kim2012,
  author = {Kim, Borah and Lee, Sang-Hyuk and Yang, Yen Kuang and Park, Jong-Il and Chung, Young-Chul},
  title = {Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons},
  journal = {Schizophrenia Research and Treatment},
  year = {2012},
  doi = {10.1155/2012/560836}
}
Kostenlos starten →